Marshall Wace
CFMS

Marshall Wace’s Conformis, Inc. Common Stock CFMS Stock Holding History

Marshall Wace’s Portfolio CFMS Stock Details CFMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,843
Closed -$46K – 3377
2021
Q1 		$46K Buy
+1,843
New +$49.7K ﹤0.01% 2392

Other funds holding CFMS

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GPCM
Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Marshall Wace's CFMS Position: Q2 2021 in Review

Marshall Wace sold out of Conformis, Inc. Common Stock (CFMS) in Q2 2021, closing a stake of 1,843 shares — an estimated $46K sold.

Marshall Wace first reported a position in CFMS in Q1 2021 and held it in 1 quarter. The position peaked at $46K in Q1 2021. 78 funds tracked by Wall St. Rank hold CFMS as of Q2 2021.

  • Marshall Wace reported no remaining Conformis, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Marshall Wace sold 1,843 Conformis, Inc. Common Stock shares in Q2 2021, an estimated $46K.
  • Marshall Wace first reported a position in Conformis, Inc. Common Stock in Q1 2021 and held it in 1 quarter.
  • Marshall Wace's Conformis, Inc. Common Stock position peaked at $46K in Q1 2021.
  • 78 funds tracked by Wall St. Rank held Conformis, Inc. Common Stock as of Q2 2021.

Based on Marshall Wace's 13F filing for Q2 2021, filed 13 Aug 2021.